• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    MPO's 2023 Medtech Supply Chain Survey

    Exceeding Medical Device Extrusion Expectations

    Medical Device Micromolders Discuss the 'Minor Details'

    Superior Subtractive Solutions for Machining Medtech

    Assembly & Automation Experts Share Thoughts on Medtech Trends
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Regulatory
    Financial/Business
    Top News
    3D Systems Partners with Klarity to Expand Distribution of VSP Bolus Solution

    Zeus Introduces Absorv XSE Oriented Tubing

    Laminate's VasQ Nabs De Novo Nod to Create AVFs for Dialysis Access

    Varian Buys Aspekt Solutions to Bolster Advanced Oncology Biz

    Patient Enrollment Ends in Biosense Webster's SmartfIRE Study
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    MPO's 2023 Medtech Supply Chain Survey

    Exceeding Medical Device Extrusion Expectations

    Medical Device Micromolders Discuss the 'Minor Details'

    Superior Subtractive Solutions for Machining Medtech

    Assembly & Automation Experts Share Thoughts on Medtech Trends
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Back to School for Medical Device Cybersecurity Training

    Driving Clinical Trial Excellence to Help Study Teams Run a Faster Relay Race

    Medtech’s Supply Chain: From Disruption to Opportunity

    Are Medtech’s Mega-Deals Gone For Good?

    Will a Skilling Gap Hinder Organizational Readiness for Medtech’s New Age of AI?
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    LEMO USA Inc.

    NDH Medical Inc.

    Arthur G. Russell Co. Inc., The

    Cirtec Medical

    Providence Enterprise USA Inc.
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    How Wearables Are Changing the Way We Collect Real-World Data in Clinical Trials

    Could Medtech Ever Stop a Hospital Killer in Their Tracks?

    A One-Stop-Shop, Turnkey Solution Is Paramount for Success

    How Additive and Subtractive Manufacturing Are Revolutionizing the Medical Device Industry

    Medical Device Commercialization: It’s What, Not When, to Transfer to Manufacturing
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    LEMO USA Inc.

    NDH Medical Inc.

    Arthur G. Russell Co. Inc., The

    Cirtec Medical

    Providence Enterprise USA Inc.
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • eBook
    • Resources
    • Podcasts
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Breaking News

    Cantel to Buy Dental Manufacturer Hu-Friedy

    Enhances the scale, competitive position, and commercial capabilities of Cantel's dental business.

    Cantel to Buy Dental Manufacturer Hu-Friedy
    PR Newswire07.30.19
    Cantel Medical Corp., a provider of instrument reprocessing and infection prevention products and services, today announced that it has entered into a definitive agreement to acquire privately-held Hu-Friedy Mfg. Co., a 111-year-old global manufacturer of instruments and instrument reprocessing workflow systems serving the dental industry. This combination creates a provider of comprehensive infection prevention, instrument and instrument management solutions to optimize dental practitioners' need for superior clinical performance and best-in-class infection prevention practices. Cantel is acquiring Hu-Friedy for $725 million in upfront cash and stock consideration, and up to $50 million in earnout payments payable in cash and stock conditional on the achievement of commercial milestones in the first eighteen months after closing. The transaction structure is anticipated to result in tax benefits to Cantel presently valued at more than $100 million, which would result in a net purchase price of $625 million for the upfront consideration and up to approximately $675 million in consideration including potential earnout payments.
     
    The company will hold a conference call to discuss the acquisition today at 8:30 a.m. Eastern Time. Call-in details are included below.
     
    Combining Hu-Friedy's leading position in dental instrumentation and instrument management systems with Cantel's leading dental infection prevention consumables meaningfully accelerates Cantel's strategy to be the leading global provider of innovative infection prevention and reprocessing workflow solutions and education across its key end markets. During the twelve-month period ended May 31, 2019, Hu-Friedy generated approximately $214 million in revenue, and adjusted EBITDA of approximately $48 million.
     
    "The combination of our two dental businesses provides a clear and immediate opportunity to become the leading provider of a 'Complete Circle of Protection' offering for instrument reprocessing workflow and infection prevention and compliance solutions in the dental industry," said George Fotiades, president and chief executive officer of Cantel. "By bringing together our highly complementary dental portfolios, we will create a business that is uniquely positioned to address the most critical workflow needs of our customers while improving patient care. Hu-Friedy brings us the scale, commercial capabilities and portfolio breadth to enable our dental business to be a significant driver of long-term profitable growth for Cantel." 
     
    "We are excited to join forces with Cantel and are looking forward to the opportunities this combination will bring for our customers, employees and other stakeholders," said Ron Saslow, chairman and chief executive officer of Hu-Friedy. "As a leader in dental instrumentation and instrument management solutions, Hu-Friedy's combination with the Cantel portfolio of leading infection prevention dental consumables is a perfect match to further enhance our ability to serve our dental customers."
     
    Hu-Friedy has built a position as a leader in the dental instruments and Instrument Management System ("IMS") categories, with a 90 percent branded portfolio, enjoying nearly 100 percent brand awareness among dentists and hygienists.
     
    Hu-Friedy has a large and sophisticated sales and customer care team, supported by a strong marketing organization using industry-leading data analytics. This will enhance Cantel's commercial and customer engagement capabilities within the dental industry, which is expected to enable long-term growth. In addition, Hu-Friedy's leading education and training offerings, well-established presence in dental schools and continued work and engagement with key opinion leaders will enable the combined business to provide a differentiated education and broad solution-based offering to the dental industry.
     
    Ron Saslow and Ken Serota, president of Hu-Friedy, will lead the combined dental business post-closing. Gary Steinberg, who has successfully built the Cantel dental division since the acquisition of Crosstex, will assist in the post-close transition and integration of these two businesses and will retire at the end of the calendar year.
     
    Under the terms of the acquisition, Cantel will pay $725 million upfront for Hu-Friedy, up to $60 million of which will be paid in Cantel stock (with the specific amount at Cantel's election) with the remainder to be paid in cash. An additional $50 million in potential cash and stock earnout payments may be payable to Hu-Friedy shareholders upon achievement of certain commercial milestones in the eighteen months following closing of the transaction.
     
    As a result of the transaction structure, the acquisition will generate an anticipated tax benefit, which Cantel has valued at more than $100 million. Cantel expects this tax benefit to positively impact cash flows over approximately 15 years. Net of this tax benefit, the total consideration implied would be $625 million upfront and up to $675 million including earnout payments.

    The combination is expected to generate annual cost synergies of at least $10 million by the third year following closing of the transaction.
     
    The acquisition is also expected to unlock potential for significant accelerated revenue growth. Cantel expects to realize potential revenue synergies by integrating Crosstex's best-in-class infection prevention consumables with Hu-Friedy's IMS product offering in new and existing IMS users. In addition, Hu-Friedy's strong presence in dental and hygiene schools represents a key opportunity to cross-sell the Cantel consumables portfolio. 
     
    Cantel expects the acquisition of Hu-Friedy to be accretive to the company's overall financial outlook. The transaction is expected to be dilutive to GAAP earnings per diluted share in fiscal year 2020 due to acquisition-related costs, but is expected to be accretive to GAAP earnings per diluted share in fiscal year 2021 and beyond. On a non-GAAP earnings basis, Cantel expects the transaction to be approximately 10 percent accretive in its fiscal year ended 2020, with mid-teens accretion in fiscal year 2021 and further accretion thereafter. The acquisition is also expected to be accretive to margins at both the divisional and Cantel levels. The company expects the transaction to exceed its cost of capital by the fourth year after closing.
     
    The cash portion of the transaction is being financed through a combination of the net proceeds of the company's amended and restated credit facility, new term loan financing and cash on hand. Cantel anticipates that the company's enhanced financial profile and scale following closing of the transaction will enable strong cash flow generation and accelerated deleveraging.
     
    The transaction has been approved by the boards of directors of both companies and is expected to close in the first quarter of Cantel's fiscal year 2020, subject to regulatory approvals and other customary closing conditions.
     
    Perella Weinberg Partners LP served as financial advisor to Cantel and Wachtell, Lipton, Rosen & Katz served as its legal advisor. Moelis & Company LLC served as financial advisor to Hu-Friedy and Latham & Watkins LLP served as its legal advisor.
    Related Searches
    • brand
    • protection
    • data
    • medical
    Suggested For You
    Precision Coating Merges with N2 Biomedical Precision Coating Merges with N2 Biomedical
    Picarro Unveils EtO Gas Concentration Analyzer Picarro Unveils EtO Gas Concentration Analyzer
    Masimo Launches Single-Patient-Use rainbow SuperSensor in Europe Masimo Launches Single-Patient-Use rainbow SuperSensor in Europe
    Stryker Buys Gauss Surgical Stryker Buys Gauss Surgical
    GE Healthcare Reveals AMX Navigate Portable X-Ray System GE Healthcare Reveals AMX Navigate Portable X-Ray System
    FDA OKs Boston Scientific FDA OKs Boston Scientific's EXALT Model B Single-Use Bronchoscope
    Metal Injection Molding and Metal 3D Printing Examination Metal Injection Molding and Metal 3D Printing Examination
    Nova POC Creatinine/eGFR Method More Accurate Than Lab Method Nova POC Creatinine/eGFR Method More Accurate Than Lab Method
    MPE Inc. Expands Into EMEA Market MPE Inc. Expands Into EMEA Market
    Interventional Systems’ Miniature Medical Robot Cleared by FDA Interventional Systems’ Miniature Medical Robot Cleared by FDA
    Medtronic’s Hugo Robotic Surgery System Makes Clinical Debut Medtronic’s Hugo Robotic Surgery System Makes Clinical Debut
    Pear Therapeutics to Become Public Company Pear Therapeutics to Become Public Company
    DARPA Enlists University to Develop AI for Portable Ultrasound DARPA Enlists University to Develop AI for Portable Ultrasound
    Halo Labs Launches Aura CL for Cell Therapy Product Quality Halo Labs Launches Aura CL for Cell Therapy Product Quality
    Katena Products Acquires ASICO LLC Katena Products Acquires ASICO LLC

    Related Breaking News

    • Surgical
      Precision Coating Merges with N2 Biomedical

      Precision Coating Merges with N2 Biomedical

      Expands its medical coatings platform.
      Ampersand Capital Partners 09.20.21

    • Picarro Unveils EtO Gas Concentration Analyzer

      Picarro Unveils EtO Gas Concentration Analyzer

      Analyzers are now available for CEMS, stack testing, fenceline, and ambient monitoring systems.
      PR Newswire 09.20.21

    • Patient Monitoring
      Masimo Launches Single-Patient-Use rainbow SuperSensor in Europe

      Masimo Launches Single-Patient-Use rainbow SuperSensor in Europe

      Uses 12 LEDs to simultaneously offer 12 blood constituent parameters noninvasively and continuously.
      Business Wire 09.13.21


    • Surgical
      Stryker Buys Gauss Surgical

      Stryker Buys Gauss Surgical

      Gains Triton AI-enabled platform for real-time monitoring of blood loss during surgery.
      PR Newswire 09.07.21

    • Diagnostics
      GE Healthcare Reveals AMX Navigate Portable X-Ray System

      GE Healthcare Reveals AMX Navigate Portable X-Ray System

      Helps address technologist stress and strain and improve efficiency.
      Business Wire 09.01.21

    Loading, Please Wait..

    Trending
    • Cardiosense Begins SEISMIC-HF I Heart Failure Trial
    • Danaher Names New Environmental And Applied Solutions Company Veralto
    • Exo Introduces The Exo Iris To Market
    • A New Approach To Post-Market Surveillance
    • Varian Buys Aspekt Solutions To Bolster Advanced Oncology Biz
    Breaking News
    • 3D Systems Partners with Klarity to Expand Distribution of VSP Bolus Solution
    • Zeus Introduces Absorv XSE Oriented Tubing
    • Laminate's VasQ Nabs De Novo Nod to Create AVFs for Dialysis Access
    • Varian Buys Aspekt Solutions to Bolster Advanced Oncology Biz
    • Patient Enrollment Ends in Biosense Webster's SmartfIRE Study
    View Breaking News >
    CURRENT ISSUE

    October 2023

    • MPO's 2023 Medtech Supply Chain Survey
    • Exceeding Medical Device Extrusion Expectations
    • Medical Device Micromolders Discuss the 'Minor Details'
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    PLT Health Solutions Granted Claims for Botanical Ingredient in Canada
    CRN Files Petition with FTC For Clarity on Health Products Compliance Guidance
    Vitafoods Europe Relocates to Barcelona Starting 2025
    Coatings World

    Latest Breaking News From Coatings World

    BASF Recognizes Hard Work with Five Prestigious Awards at SEMA
    Arkema Will Decarbonize Acrylics Production at its Carling, France Site
    PPG to Announce Third-Quarter 2023 Results October 18
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    3D Systems Partners with Klarity to Expand Distribution of VSP Bolus Solution
    Zeus Introduces Absorv XSE Oriented Tubing
    Laminate's VasQ Nabs De Novo Nod to Create AVFs for Dialysis Access
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Ono, Admid Partner on Novel Antibody Drugs in Oncology
    Theradaptive Awarded DOD Clinical Trial Award of up to $7.4M
    Ginkgo Bioworks, Pfizer Enter Multi-Target RNA Discovery Alliance
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    NYX Professional Makeup Partners with the New York Liberty
    BASF and StitchCrew Introduce Educational Bootcamp for Indigenous Beauty Brands
    Top 10 Most Popular Fashion Designer Makeup Brands—According to Landys Chemist
    Happi

    Latest Breaking News From Happi

    Color Street to Donate $35K for Breast Cancer Awareness
    Evoke the Beauty of Spring with Epopack
    Micro Powders Appoints IMCD US New Regional Distributor for Personal Care Products
    Ink World

    Latest Breaking News From Ink World

    Arkema Will Decarbonize Acrylics Production at Carling, France Site
    Micro Powders Showcases New Natural, PTFE Alternative Additives at 2023 WCS
    Roland DG Direct-To-Film Printer Ink, Powder Receive ECO PASSPORT Certification
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    INX brings inkjet and sustainable packaging to PRINTING United Expo
    Schreiner MediPharm introduces Freeze-Light-Protect syringe label
    Kodak launches PRINERGY 10.0
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    ExxonMobil Works with JL Goor to Help Drive Growth in Ireland and U.K. Healthcare Sector
    Lee C. Stewart Resigns from Glatfelter Board
    Ana Fraisse Joins The American Cleaning Institute
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    CTL Amedica Granted ECAT Approval from Defense Logistics Agency
    Intech Acquires Lenkbar LLC
    ONWARD Completes First-in-Human for ARC-IM to Restore Upper Extremity Function
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Nearly Six in 10 Warehouse Leaders Plan to Deploy RFID by 2028: Zebra
    Wiliot to Show Enhanced Version of Wiliot Cloud, IoT Pixels, at MWC Las Vegas 2023
    Fraunhofer FEP Integrable Solution for 2D Inline Process Monitoring

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login